Article Text

PDF
Clinical outcome of coronary stenting after thoracic radiotherapy: a case-control study
  1. Christophe L Dubois1,
  2. Christos Pappas1,
  3. Ann Belmans1,2,
  4. Katrien Erven3,
  5. Tom Adriaenssens1,
  6. Peter Sinnaeve1,
  7. Mark Coosemans1,
  8. Peter Kayaert1,
  9. Caroline Weltens3,
  10. Walter Desmet1
  1. 1Department of Cardiology, University Hospitals Leuven, Leuven, Belgium
  2. 2Department of Public Health, Biostatistical Centre, Catholic University Leuven, Leuven, Belgium
  3. 3Department of Radiotherapy, University Hospitals Leuven, Leuven, Belgium
  1. Correspondence to Dr Christophe L Dubois, Department of Cardiology, University Hospital Gasthuisberg Leuven, Herestraat 49, Leuven B 3000, Belgium; christophe.dubois{at}uzleuven.be

Abstract

Objective Patients with lymphoma, lung or breast neoplasia show significant improvement in their disease-specific survival after radiotherapy (RT), but these benefits may be offset by delayed effects of irradiation of the heart. We compared clinical outcome after coronary stenting in patients with neoplastic disease and previous thoracic RT with matched patients without previous RT.

Design Single-centre retrospective case-control study.

Patients and methods Each patient with former thoracic RT undergoing coronary stenting between June 1998 and June 2005 was matched to two control patients according to several known prognostic factors (gender, age, available follow-up, stented vessel, drug-eluting stent use, unstable coronary disease, renal insufficiency, diabetes, bifurcational disease, stent length and size and ejection fraction).

Main outcome measures Major adverse cardiac events (MACE) were defined as the composite of cardiac death, acute myocardial infarction (AMI) and target lesion revascularisation (TLR) and were assessed at latest follow-up and compared using Cox regression analyses.

Results 41 patients underwent coronary stenting at 6±4 years after RT. Clinical outcome at 5±2 years after stenting was compared with outcome in 82 matched patients. For all-cause mortality, the hazard ratio for RT versus no RT was 4.2 (95% CI 1.8 to 9.5; p=0.0006). For cardiac mortality, the estimated hazard ratio was 4.2 (95% CI 1.0 to 17.0; p=0.0451). No significant differences were detected in terms of AMI, TLR, MACE or stent thrombosis.

Conclusions Our findings suggest an increased risk of all-cause and cardiac mortality in patients who underwent coronary stent implantation after previous thoracic RT. Verification in larger patient populations is warranted.

  • Radiation therapy
  • coronary stenting

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.